Reference
Health Canada. Summary Safety Review - STELARA (ustekinumab) - Serious Skin Disorders (Exfoliative Dermatitis and Erythrodermic Psoriasis). Internet Document : 24 Nov 2014. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/stelara-eng.php
Rights and permissions
About this article
Cite this article
Ustekinumab: risk of serious skin disorders. Reactions Weekly 1531, 10 (2014). https://doi.org/10.1007/s40278-014-5643-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-5643-3